Introduction
============

Japan\'s current elderly population has reached its highest number at 33 million, and the proportion of elderly in the overall population reached 26.0% in 2014^[@bib1])^. An estimated 13.3 million patients have chronic kidney disease (CKD), and more than 310000 are estimated to require chronic dialysis treatment. Accordingly, CKD has become a major public health issue^[@bib2])^.

CKD has been recognized as an independent risk factor for all-cause death and cardiovascular disease (CVD) onset as well as end-stage renal disease^[@bib3]--[@bib7])^, and thus early detection and treatment are important for the control of modifiable cardiovascular risk factors. Although cardiovascular risk factors, such as hypertension, diabetes mellitus, and dyslipidemia, have been addressed as predictive factors for CKD^[@bib8],\ [@bib9])^, other predictive factors have not been well elucidated.

The Atherosclerosis Risk in Communities Study and the Second National Health and Nutrition Examination Survey showed an inverse association between serum albumin levels and the risk of incident CKD in middle-aged adults^[@bib10],\ [@bib11])^. Furthermore, the Cardiovascular Health Study reported that lower serum albumin and higher CRP levels were associated with the progression of kidney dysfunction in elderly subjects aged ≥ 65 years^[@bib12])^.

Aim
===

We hypothesized serum albumin and high-sensitivity C-reactive protein (hs-CRP) to be independent markers of incident CKD. Thus, in this study, we examined their associations with the risk of incident CKD during an 11-year prospective cohort study.

Methods
=======

Study Population
----------------

The Circulatory Risk in Communities Study (CIRCS) is an ongoing dynamic community cohort study involving five communities in Japan for which the study design and procedural details have been published elsewhere^[@bib13])^. The subjects, who ranged in age from 40 to 69 years, resided in two communities from which the CIRCS populations were drawn: the town of Ikawa (a rural community in the Akita Prefecture, northwestern Japan) and the Minami-Takayasu district in Yao City (a suburb of the Osaka Prefecture, midwestern Japan). A total of 3126 subjects (1082 men and 2044 women) participated in the baseline cardiovascular risk surveys between 2002 and 2003, including 1217 (492 men and 725 women) in Ikawa and 1909 (590 men and 1319 women) in Yao. Of these, 2828 subjects (958 men and 1870 women) participated in at least one follow-up examination (and thus had available data) before the end of 2013. Additionally, we excluded eight subjects without serum data, 265 with a low eGFR (\<60 mL/min per 1.73 m^2^) and/or urine protein level (1+/or more), 2 with prevalent kidney disorders, and 18 with prevalent liver disorders at the baseline survey. Therefore, a total of 2535 subjects (821 men and 1714 women) were finally enrolled in this study and followed up until the end of 2013 to determine incident CKD.

Informed consent was given verbally by community leaders and individual participants, according to the common practice in Japanese communities at that time. The CIRCS was approved by the ethics committees of the Osaka Center for Cancer and Cardiovascular Diseases Prevention and Osaka University Graduate School of Medicine.

Baseline Examination
--------------------

Serum creatinine levels were assayed using an enzymatic method, and the GFR was estimated using an established method proposed by a working group of the Japanese Chronic Kidney Disease initiative^[@bib14])^ as follows:

eGFR (ml/min per 1.73 m^2^) = 194 × \[serum creatinine (enzyme method)\]^−1.094^ × (age)^−0.287^ × (0.739 for women).

CKD was defined as a GFR \< 60 mL/min per 1.73 m^2^, in accordance with the National Kidney Foundation Kidney Disease Outcomes Quality Initiative guidelines^[@bib15])^. Serum albumin levels were analyzed using Bartholomew and Delaney\'s bromcresol green method and an AU2 700 automatic biochemical analyzer (Olympus, Tokyo, Japan). hs-CRP levels were determined using an automated immunonephelometric assay (Behring Nephelometer Protein Specific with N Latex CRP II; Dade Behring Inc., Tokyo, Japan).

BMI was calculated as the body weight (kg) divided by the height squared (m^2^). Height was measured while the subjects were in stocking feet, and weight was determined while the subjects wore light clothing. An interview was conducted to ascertain the smoking status, usual weekly alcohol intake, and diabetes mellitus, hypertension, or hyperlipidemia medication use.

Blood pressure levels were measured by trained physicians using standard mercury sphygmomanometers and standardized epidemiological methods^[@bib16])^. Diabetes mellitus was defined as a fasting glucose level of ≥ 7.0 mmol/L (≥ 126 mg/dL), a non-fasting glucose level of ≥ 11.1 mmol/L (≥ 200 mg/dL), and/or diabetes medication use.

Follow-up Surveillance (Endpoint Determination)
-----------------------------------------------

The follow-up was conducted through annual cardiovascular risk surveys. For each participant, the number of person-years of follow-up was calculated as the sum of the individual follow-up time from the date of the baseline survey to the date of incident CKD or the latest exam without incident CKD, whichever occurred first.

Statistical Analysis
--------------------

Differences in participant characteristics, defined as the age-adjusted mean values of baseline CKD risk factors, were compared through an analysis of variance; the F test was used for continuous variables and the chi-square test was used to compare percentages among the serum albumin and hs-CRP quartiles. We choconducted tests for linear trends of covariates using the median values of serum albumin and hs-CRP quartiles. Cox proportional hazards regression models were used to calculate sex-specific hazard ratios and 95% CIs for incident CKD using the risks for subjects with the lowest quartiles of serum albumin, hs-CRP levels, and their combinations as reference.

The initial model was adjusted only for age and community, whereas the variables adjusted in the multivariable analysis included age, community, BMI (kg/m^2^), smoking status (never and former versus current), systolic blood pressure (mmHg), antihypertensive medication use (yes versus no), serum total cholesterol level (mg/dL), hyperlipidemia medication use (yes versus no), diabetes mellitus (yes versus no), eGFR (mL/min per 1.73 m^2^), and either hs-CRP (mg/L) or serum albumin (g/dL), depending on the exposure variable.

The significance of the interactions for sex was tested using cross-product terms of sex with serum albumin and hs-CRP levels, and we also checked the cross-product terms of serum albumin with hs-CRP levels.

All statistical analyses were conducted using SAS statistical software package, version 9.3 (SAS Institute, Inc., Cary, NC, USA). All statistical analyses were two-tailed, and a *p*-value \< 0.05 was considered statistically significant.

Results
=======

A total of 367 cases (123 men and 244 women) of incident CKD were identified during a median 9.0-year follow-up, yielding a total of 19413 person-years. **[Table 1](#T1){ref-type="table"}** shows the sex-specific, age-adjusted mean values and prevalence rates of selected CKD risk factors at the baseline, according to quartiles of serum albumin levels. The average age was 58.6 years for men and 57.1 years for women.

###### Sex-specific, age-adjusted mean values and prevalence rates of baseline risk characteristics according to quartiles of serum albumin levels

                                                 Quartiles of serum albumin levels                                                               
  ---------------------------------------------- ----------------------------------- ------ ------ ------ ---------- ------ ------ ------ ------ ----------
  Number of participants                         174                                 262    152    233               349    634    301    430    
  Age (y)                                        61.0                                59.2   58.6   56.3   \< 0.001   56.6   57.1   57.3   57.3   0.206
  Serum creatinine (mg/dL)                       0.75                                0.76   0.76   0.75   0.829      0.58   0.57   0.58   0.58   0.726
  eGFR (mL/min per 1.73 m^2^)                    85.1                                83.4   83.9   84.4   0.778      84.4   85.1   84.1   84.4   0.765
  Body mass index (kg/m^2^)                      23.7                                23.8   24.1   24.1   0.201      23.2   23.2   23.3   22.8   0.044
  Current smokers (%)                            51                                  44     42     37     0.004      6      5      4      5      0.456
  Alcohol intake (ethanol g/day)                 28.4                                27.0   26.3   26.4   0.450      2.3    2.1    1.6    2.1    0.74
  hs-CRP (mg/L)                                  1.86                                1.18   1.10   0.84   0.003      2.02   0.96   0.73   0.62   \< 0.001
  Systolic blood pressure (mmHg)                 125                                 129    130    131    \< 0.001   122    124    125    128    \< 0.001
  Diastolic blood pressure (mmHg)                78                                  81     82     83     \< 0.001   74     76     76     77     \< 0.001
  Use of antihypertensive medication (%)         15                                  16     15     25     0.010      12     14     14     22     \< 0.001
  Serum total cholesterol (mg/dL)                195                                 202    213    216    \< 0.001   211    220    224    231    \< 0.001
  High-density lipoprotein cholesterol (mg/dL)   58                                  58     59     61     0.009      65     65     66     68     \< 0.001
  Cholesterol-lowering medication (%)            3                                   3      2      6      0.180      8      9      9      15     \< 0.001
  Diabetes mellitus (%)                          9                                   4      11     12     0.115      4      3      4      5      0.135

Median values are shown.

Abbreviations: hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate.

For men, the mean systolic blood pressure, diastolic blood pressure, serum total cholesterol, and high-density lipoprotein (HDL)-cholesterol values and the prevalence rates of antihypertensive medication use were higher and the mean hs-CRP value and prevalence of current smokers were lower among those with higher serum albumin levels. For women, the mean systolic blood pressure, diastolic blood pressure, serum total cholesterol, and HDL-cholesterol values and the prevalence rates of antihypertensive and cholesterol-lowering medication use were higher, whereas the mean body mass index (BMI) and hs-CRP values were lower among those with higher serum albumin levels.

**[Table 2](#T2){ref-type="table"}** shows the sex-specific, age-adjusted mean values and prevalence rates of selected CKD risk factors at the baseline, according to quartiles of hs-CRP levels. For men, the mean BMI and systolic blood pressure values and the prevalence rates of antihypertensive and cholesterol-lowering medication use, and current smokers were higher and the mean HDL-cholesterol level was lower in those with higher hs-CRP levels. For women, the mean BMI, systolic blood pressure, and diastolic blood pressure values and the prevalence rates of antihypertensive medication use, diabetes mellitus were higher, whereas the mean serum albumin and HDL-cholesterol values were lower in those with higher hs-CRP levels.

###### Sex-specific, age-adjusted mean values and prevalence rates of baseline risk characteristics according to quartiles of hs-CRP levels

                                                 Quartiles of hs-CRP levels                                                               
  ---------------------------------------------- ---------------------------- ------ ------ ------ ---------- ------ ------ ------ ------ ----------
  Number of participants                         205                          206    205    205               427    430    429    428    
  Age (y)                                        58.2                         58.1   59.3   58.9   0.283      54.2   57.3   58.0   58.8   \< 0.001
  Serum creatinine (mg/dL)                       0.76                         0.75   0.76   0.75   0.233      0.58   0.57   0.57   0.57   0.604
  eGFR (mL/min per 1.73m^2^)                     83.5                         84.8   83.2   85.0   0.382      84.2   84.8   84.4   85.0   0.460
  Body mass index (kg/m^2^)                      22.8                         23.7   24.5   24.7   \< 0.001   21.3   22.8   24.0   24.4   \< 0.001
  Current smokers (%)                            31                           45     48     50     0.003      5      5      5      6      0.321
  Alcohol intake (ethanol g/day)                 23.7                         28     28.9   27.3   0.463      1.7    2.3    1.7    2.4    0.212
  Serum albumin (g/dL)                           4.53                         4.54   4.56   4.50   0.092      4.53   4.53   4.53   4.48   \< 0.001
  Systolic blood pressure (mmHg)                 126                          128    130    131    0.002      121    124    126    127    \< 0.001
  Diastolic blood pressure (mmHg)                80                           81     81     82     0.145      74     76     77     77     \< 0.001
  Use of antihypertensive medication (%)         14                           16     19     23     0.012      9      13     21     20     \< 0.001
  Serum total cholesterol (mg/dL)                202                          208    209    207    0.339      220    223    224    220    0.521
  High-density lipoprotein cholesterol (mg/dL)   64                           61     57     55     \< 0.001   72     68     64     61     \< 0.001
  Cholesterol-lowering medication (%)            2                            3      4      6      0.008      8      9      13     10     0.669
  Diabetes mellitus (%)                          7                            8      9      10     0.25       4      3      4      5      0.040

Median values are shown.

Abbreviations: hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate.

**[Table 3](#T3){ref-type="table"}** shows the sex-specific, age-adjusted multivariable hazard ratios of CKD according to quartiles of serum albumin levels. For both men and women, a lower risk of CKD was observed for the second to fourth quartiles of serum albumin level than for the lowest quartile of serum albumin level. This association became even stronger after adjusting for known CKD risk factors. The multivariable hazard ratios \[95% confidence intervals (CI)\] of CKD for the highest versus the lowest quartile of serum albumin levels were 0.69 (0.40--1.17) for men and 0.42 (0.28--0.64) for women, and the sex interaction was of borderline statistical significance (*P* for interaction = 0.062). Furthermore, the multivariable hazard ratios (95% CI) of CKD for the combined category of the second to fourth quartiles versus the lowest quartile of serum albumin levels were 0.65 (0.42--1.00) for men and 0.74 (0.54--1.01) for women (data not shown).

###### Hazard ratios (HRs) of incident chronic kidney disease according to quartiles of serum albumin levels

                                                          Quartiles of serum albumin                                           
  ------------------------------------------------------- ---------------------------- ------------------- ------------------- -------------------
  Men                                                                                                                          
      Number at risk                                      174                          262                 152                 233
      Person years                                        1247                         1984                1183                1787
      Number of cases (%)                                 32 (18.4)                    41 (15.7)           19 (12.5)           31 (13.3)
      Incidence, per 1000 person-years                    25.7                         20.7                16.1                17.3
      Age and community-adjusted HR                       1.00                         0.83 (0.52--1.32)   0.69 (0.39--1.21)   0.88 (0.53--1.46)
  Multivariable HR^[\#](#tf3){ref-type="table-fn"}^       1.00                         0.63 (0.38--1.04)   0.64 (0.36--1.16)   0.69 (0.40--1.17)
                                                                                                                               
  Women                                                                                                                        
      Number at risk                                      349                          634                 301                 430
      Person years                                        2596                         4831                2319                3464
      Number of cases (%)                                 57 (16.3)                    96 (15.1)           43 (14.3)           48 (11.2)
      Incidence, per 1000 person-years                    22.0                         19.9                18.5                13.9
      Age and community-adjusted HR                       1.00                         0.86 (0.62--1.19)   0.82 (0.55--1.22)   0.60 (0.41--0.88)
      Multivariable HR^[\#](#tf3){ref-type="table-fn"}^   1.00                         0.95 (0.68--1.34)   0.82 (0.55--1.23)   0.42 (0.28--0.64)
                                                                                                                               
  Total subjects                                                                                                               
      Number at risk                                      523                          896                 453                 663
      Person years                                        3844                         6816                3502                5251
      Number of cases (%)                                 89 (17.0)                    137 (15.3)          62 (13.7)           79 (11.9)
      Incidence, per 1000 person-years                    23.2                         20.1                17.7                15.0
      Sex, age and community-adjusted HR                  1.00                         0.87 (0.66--1.13)   0.78 (0.57--1.09)   0.68 (0.51--0.93)
      Multivariable HR^[\#](#tf3){ref-type="table-fn"}^   1.00                         0.88 (0.67--1.15)   0.78 (0.56--1.09)   0.52 (0.38--0.72)

The multivariable adjusted HR was further adjusted for body mass index, smoking status, systolic blood pressure, antihypertensive medication use, diabetes mellitus, serum total cholesterol, cholesterol-lowering medication use, estimated glomerular filtration rate, and high-sensitivity C-reac-tive protein levels.

Abbreviations: Q, quartile.

**[Table 4](#T4){ref-type="table"}** shows the sex-specific, age-adjusted multivariable hazard ratios of CKD according to quartiles of hs-CRP levels. Although risk of incident CKD tended to be higher for the second to fourth highest quartiles of hs-CRP levels, this association became null for men after adjusting for the known CKD risk factors. For women, compared with the lowest quartile, an excess risk of incident CKD was observed for the highest quartile of hs-CRP levels, and this association became stronger after adjusting for known CKD risk factors. The multivariable hazard ratio (95% CI) of CKD for the highest versus the lowest quartiles of hs-CRP levels was 1.85 (1.25--2.75) for women, with the sex interaction of statistical significance (*P* for interaction = 0.078). Furthermore, the multivariable hazard ratio (95% CI) of CKD for the highest quartile versus the combined category of the first to third quartiles of hs-CRP levels was 1.67 (1.27--2.19) for women (data not shown).

###### Hazard ratios (HRs) of incident chronic kidney disease according to quartiles of hs-CRP levels

                                                          Quartiles of hs-CRP                                           
  ------------------------------------------------------- --------------------- ------------------- ------------------- -------------------
  Men                                                                                                                   
      Number at risk                                      205                   206                 205                 205
      Person years                                        1589                  1518                1489                1607
      Number of cases (%)                                 27 (13.2)             31 (15.0)           33 (16.1)           32 (15.6)
      Incidence, per 1000 person-years                    17.0                  20.4                21.9                19.9
      Age and community-adjusted HR                       1.00                  1.20 (0.72--2.02)   1.18 (0.71--1.97)   1.12 (0.67--1.88)
      Multivariable HR^[\#](#tf4){ref-type="table-fn"}^   1.00                  1.01 (0.59--1.74)   0.90 (0.53--1.54)   0.95 (0.54--1.67)
                                                                                                                        
  Women                                                                                                                 
      Number at risk                                      427                   430                 429                 428
      Person years                                        3304                  3340                3423                3143
      Number of cases (%)                                 41 (9.6)              55 (12.8)           58 (13.5)           90 (21.0)
      Incidence, per 1000 person-years                    12.4                  16.5                16.9                28.6
      Age and community-adjusted HR                       1.00                  1.08 (0.72--1.62)   1.07 (0.72--1.60)   1.72 (1.18--2.50)
      Multivariable HR^[\#](#tf4){ref-type="table-fn"}^   1.00                  1.30 (0.86--1.97)   1.05 (0.68--1.60)   1.85 (1.25--2.75)
                                                                                                                        
  Total subjects                                                                                                        
      Number at risk                                      632                   636                 634                 633
      Person years                                        4893                  4858                4912                4750
      Number of cases (%)                                 68 (10.8)             86 (13.5)           91 (14.4)           122 (19.3)
      Incidence, per 1000 person-years                    13.9                  17.7                18.5                25.7
  Sex, age and community-adjusted HR                      1.00                  1.12 (0.81--1.54)   1.11 (0.81--1.53)   1.51 (1.12--2.04)
      Multivariable HR^[\#](#tf4){ref-type="table-fn"}^   1.00                  1.16 (0.84--1.61)   0.97 (0.70--1.35)   1.52 (1.10--2.08)

The multivariable-adjusted HR was further adjusted for body mass index, smoking status, systolic blood pressure, antihypertensive medication use, diabetes mellitus, serum total cholesterol, cholesterol-lowering medication use, estimated glomerular filtration rate, and serum albumin levels. Abbreviations: hs-CRP, high-sensitivity C-reactive protein; Q, quartile.

**[Table 5](#T5){ref-type="table"}** shows the associations between the combination of serum albumin (the lowest versus higher quartiles) and hs-CRP (the highest versus lower quartiles) and the risk of CKD for women. The positive association between low serum albumin level and the risk of CKD was observed in the subgroup of lower hs-CRP levels, but not of high hs-CRP level. The multivariable hazard ratio (95% CI) of CKD for the lowest versus higher quartiles of serum albumin levels was 1.72 (1.17--2.54) in the subgroup of lower hs-CRP levels. The positive association between high hs-CRP level and the risk of CKD was observed in the subgroup of higher albumin levels, but not of low albumin level. The multivariable hazard ratio (95% CI) of CKD for the highest versus lower hs-CRP levels was 1.96 (1.44--2.66) in the subgroup of higher albumin levels, with hs-CRP and serum albumin interaction of statistical significance (*P* for interaction = 0.035).

###### Hazard ratios (HRs) of incident chronic kidney disease according to two categories of serum albumin or hs-CRP levels, stratified by hs-CRP or serum albumin levels for women

                                                      Lower hs-CRP (Q1--Q3)   High hs-CRP (Q4)                
  --------------------------------------------------- ----------------------- ------------------- ----------- -------------------
  Number at risk                                      1050                      236                 315       113
  Person years                                        8301                    1767                2314        830
  Number of cases (%)                                 119 (11.3)              35 (14.8)           68 (21.6)   22 (19.5)
  Incidence, per 1000 person-years                    14.3                    19.8                29.4        26.5
  Age- and community-adjusted HR                      1.00                    1.59 (1.09--2.32)   1.00        0.82 (0.51--1.33)
  Multivariable HR^[\#](#tf5){ref-type="table-fn"}^   1.00                    1.72 (1.17--2.54)   1.00        0.89 (0.54--1.44)

                                                      Higher albumin (Q2--Q4)   Low albumin (Q1)                
  --------------------------------------------------- ------------------------- ------------------- ----------- -------------------
  Number at risk                                      1050                        315                 236       113
  Person years                                        8301                      2314                1767        830
  Number of cases (%)                                 119 (11.3)                68 (21.6)           35 (14.8)   22 (19.5)
  Incidence, per 1000 person-years                    14.3                      29.4                19.8        26.5
  Age- and community-adjusted HR                      1.00                      1.87 (1.39--2.52)   1.00        0.96 (0.56--1.65)
  Multivariable HR^[\#](#tf5){ref-type="table-fn"}^   1.00                      1.96 (1.44--2.66)   1.00        1.01 (0.58--1.73)

The multivariable-adjusted HR was further adjusted for body mass index, smoking status, systolic blood pressure, antihypertensive medication use, diabetes mellitus, serum total cholesterol, cholesterol-lowering medication use, and estimated glomerular filtration rate.

Abbreviations: hs-CRP, high-sensitivity C-reactive protein; Q, quartile.

Discussion
==========

In this large prospective cohort study of middle-aged Japanese residents, we identified an association between low serum albumin levels (≤ 4.3 g/dL) and a two-fold higher risk of incident CKD; notably, this association was more evident for women than for men. We also found that higher hs-CRP levels (≤0.78 mg/L) were associated with a two-fold higher risk of incident CKD for women but not for men. When the serum albumin and hs-CRP categories were combined, the risk of CKD was 2.0-fold higher for women with higher serum albumin and high hs-CRP than for those with higher serum albumin and lower hs-CRP.

To the best of our knowledge, this is the first population-based prospective cohort study to examine the associations of serum albumin and hs-CRP levels with the risk of CKD. A 14-year follow-up study of American men and women aged 45--64 years, who were free from CKD at the baseline, identified a strong inverse association between serum albumin levels and the risk of CKD. In that study, the multivariable hazard ratio (95% CI) of CKD after adjusting for age, race, sex, smoking, blood pressure, diabetes, log triglycerides, HDL, low-density lipoprotein (LDL), prior myocardial infarction, antihypertensive use, alcohol use, year of marker measurement, and baseline estimated glomerular filtration rate (eGFR) was 0.63 (0.55--0.72) for the highest versus the lowest quartile of serum albumin levels (ï4.1 g/dL versus \< 3.7 g/dL)^[@bib10])^, which was consistent with our finding.

A 15-year follow-up of 2877 subjects aged 43--84 years in the Beaver Dam Chronic Kidney Disease Study found that hs-CRP levels were not associated with the risk of incident CKD. The multivariable hazard ratio (95% CI) of CKD after adjusting for age, sex, education, smoking, alcohol intake, BMI, glycosylated hemoglobin, mean arterial blood pressure, and serum total cholesterol was 1.14 (0.95--1.37) for the highest (men: \> 2.60 mg/dL and women: \> 2.99 mg/dL) versus the lowest CRP tertile (men: \< 1.13 mg/dL and women: \< 1.19 mg/dL). However, this study did not report sex-specific results^[@bib17])^. During a median 9.0-year follow-up in our study, the risk of CKD for women was two-fold higher at the highest hs-CRP level (≤ 0.78 mg/L) than at the lowest hs-CRP level (\< 0.17 mg/L); notably, these hs-CRP levels were much lower than those reported for Caucasians^[@bib18],\ [@bib19])^.

The functions of serum albumin are to maintain normal microvessel wall permeability, inhibit platelet aggregation, and reduce blood viscosity^[@bib20]--[@bib22])^. In addition, serum albumin acts as an extracellular antioxidant by inhibiting the formation of oxidized LDL-cholesterol^[@bib23])^ and by binding and thus preventing the toxic effects of free fatty acids in the serum^[@bib24])^. Accordingly, low serum albumin levels have been associated with the risks of myocardial infarction, atrial fibrillation, cardiovascular disease, and death^[@bib25]--[@bib28])^.

During the process of atherogenesis, CRP accelerates LDL uptake by macrophages, leading to the formation of foam cells^[@bib29])^. CRP also impairs endothelial function by attenuating the nitric oxide production through the downregulation of endothelial nitric oxide synthase mRNA and facilitates the apoptosis of endothelial cells^[@bib30])^. Furthermore, CRP stimulates the proliferation and migration of vascular smooth muscle cells^[@bib31],\ [@bib32])^.

The reported median hs-CRP levels in Japanese populations have been relatively lower than those in Western populations^[@bib33]--[@bib36])^. In this study, the median hs-CRP values of 0.48 mg/L for men and 0.36 mg/L for women were approximately one third of the median value reported for Caucasian men (1.7 mg/L) and one seventh of the median values reported for Caucasians women (2.0--3.2 mg/L)^[@bib18],\ [@bib19])^. A previous Japanese study reported significant correlations of hs-CRP levels with BMI, systolic blood pressure, diastolic blood pressure, total cholesterol (women only), LDL-cholesterol (women only), HDL-cholesterol, triglycerides, fasting glucose, overweight, hypertension, dyslipidemia, diabetes, cardiovascular history (men only), and smoking (men only)^[@bib36])^. In our study, a positive correlation with diastolic blood pressure was only found for women.

In our study, we measured two markers of inflammation, i.e., serum albumin and hs-CRP levels and examined their combined associations with the risk of incident CKD. We identified the associations between low serum albumin or high hs-CRP and the risk of CKD in the subgroup of lower hs-CRP or higher serum albumin levels, respectively, but these association were not observed in the other subgroups. We could not elucidate the mechanism of this result from our study, but we considered that serum albumin and hs-CRP levels are independent risk factors of developing CKD.

Furthermore, we found that low serum albumin and high hs-CRP levels were predictive for CKD for women but not for men. However, previous studies did not report sex-specific results; hence, we did not examine the consistency of the findings.

The strengths of our study include its large sample size, prospective design, and long-term follow-up, during which surveys were annually conducted to verify the participants\' vital statuses. Also, as our findings were determined from a community-based population without CKD at the baseline, it is likely that they can be extrapolated to general Japanese populations. Furthermore, we examined the association of serum hs-CRP levels with the risk of incident CKD in subpopulations stratified by serum albumin levels, which allowed us to examine the joint impact of these two biomarkers on the risk of incident CKD.

Regarding study limitations, CKD in this study was defined using a single creatinine measurement. However, a previous study reported fairly good repeatability for CKD diagnosis; as the coefficients of variation for serum creatinine in the present study were 0.6%--0.7%, the potential for misclassification may be low.

Conclusion
==========

This prospective cohort study found that both low serum albumin and high hs-CRP levels were independent predictors of incident CKD in middle-aged Japanese women.
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